Tocqueville Asset Management L.P. Pfizer Inc Transaction History

Tocqueville Asset Management L.P.

$6.05 Billion
Q1 2024

A detailed history of Tocqueville Asset Management L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 1,514,753 shares of PFE stock, worth $42.4 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

1,514,753

Previous 1,055,140 43.56%

Holding current value

$42.4 Million

Previous $30.4 Million 38.37%

% of portfolio

0.69%

Previous 0.56%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $11.9 Million - $13.7 Million	459,613 Added 43.56%	1,514,753 $42 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $3.56 Million - $4.62 Million	-136,217 Reduced 11.43%	1,055,140 $30.4 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $3.62 Million - $4.23 Million	-112,766 Reduced 8.65%	1,191,357 $39.5 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $1.47 Million - $1.7 Million	40,726 Added 3.22%	1,304,123 $47.8 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $3.04 Million - $3.95 Million	77,091 Added 6.5%	1,263,397 $51.5 Million

Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $373,829 - $487,993	-8,954 Reduced 0.75%	1,186,306 $60.8 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $1.22 Million - $1.49 Million	-27,883 Reduced 2.28%	1,195,260 $52.3 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $1.57 Million - $1.86 Million	-33,679 Reduced 2.68%	1,223,143 $64.1 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $1.09 Million - $1.35 Million	-23,861 Reduced 1.86%	1,256,822 $65.1 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $1.12 Million - $1.66 Million	-27,098 Reduced 2.07%	1,280,683 $75.6 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $2.74 Million - $3.52 Million	-69,891 Reduced 5.07%	1,307,781 $56.2 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $6.85 Million - $7.75 Million	-190,620 Reduced 12.15%	1,377,672 $54 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $2.09 Million - $2.36 Million	62,469 Added 4.15%	1,568,292 $56.8 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $3.03 Million - $3.86 Million	-90,670 Reduced 5.68%	1,505,823 $55.4 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $2.81 Million - $3.29 Million	88,357 Added 5.86%	1,596,493 $58.6 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $101,173 - $122,737	-3,359 Reduced 0.22%	1,508,136 $49.3 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $4.7 Million - $6.71 Million	173,812 Added 12.99%	1,511,495 $49.3 Million
Q4 2019 Jan 14, 2020	BUY	$32.92 - $37.36 $729,935 - $828,383	22,173 Added 1.69%	1,337,683 $52.4 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $2.05 Million - $2.65 Million	-62,966 Reduced 4.57%	1,315,510 $47.3 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $725,695 - $814,788	-19,624 Reduced 1.4%	1,378,476 $59.7 Million
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $1.18 Million - $1.3 Million	-31,498 Reduced 2.2%	1,398,100 $59.4 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $2.5 Million - $2.85 Million	-64,954 Reduced 4.35%	1,429,598 $62.4 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $253,561 - $307,554	7,356 Added 0.49%	1,494,552 $65.9 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $2.99 Million - $3.18 Million	-90,574 Reduced 5.74%	1,487,196 $54 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $6.14 Million - $7.12 Million	-192,277 Reduced 10.86%	1,577,770 $56 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $6.21 Million - $6.59 Million	-186,685 Reduced 9.54%	1,770,047 $64.1 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $60.7 Million - $66.8 Million	1,956,732	1,956,732 $69.9 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account

Tocqueville Asset Management L.P. Pfizer Inc Transaction History